×

Promising 3 billion doses of Covid-19 vaccine by the end of the year

Promising 3 billion doses of Covid-19 vaccine by the end of the year 5

Promising 3 billion doses of Covid-19 vaccine by the end of the year

AstraZeneca CEO said this information, along with the third quarter profit report, on November 5.

Last month, European officials began a rolling review of AstraZeneca’s vaccine trial data in conjunction with Oxford.

The company is expanding production and frozen storage to extend the `life` of the vaccine.

CEO Pascal Soriot is confident that the pharmaceutical company can supply hundreds of millions of doses by January next year.

AstraZeneca and Oxford pledged to produce and sell 3 billion doses of the vaccine without making a profit when successful, the price of a shot is 4 USD or less.

AstraZeneca’s Covid-19 vaccine combined with Oxford University, named AZD1222, is one of the leading candidates in the global Covid-19 vaccine race.

Vaccine testing continues after weeks of being stopped in the US because a volunteer had unexplained neurological symptoms.

According to initial data published previously, AstraZeneca’s Covid-19 vaccine showed promising immune responses, mild side effects in the elderly and the elderly.

AstraZeneca said third-quarter profits doubled, while revenue was slightly below analysts’ expectations.

AstraZeneca believes it is on track with its full-year plan, but it is uncertain whether the pandemic will slow down the pace of many other treatment requests.

AstraZeneca’s vaccine called AZD1222, in the leading group in the world’s vaccine race, is expected to limit infections and deaths from nCoV, supporting global economic recovery.

The pandemic is continuing to spread in many areas, especially in the US and Europe.

This week, the US reported more than 100,000 new Covid-19 cases every day, with total infections exceeding 10 million.

The epidemic has claimed more than 1.2 million lives globally, since the end of January.

Post Comment